Effects of peptide ingestion on sleep: a randomized, double-blind, placebo-controlled, parallel-group study

Not Applicable

• Conditions: o

• Registration Number: JPRN-UMIN000043407
• Lead Sponsor: everage Brain Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-24
• Study Completion: 2021-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who are undergoing medical treatment or diagnosed as needing medical treatment 2) Subjects who are pregnant, lactation, or planning to become pregnant during this study 3) Subjects who have history of serious disorders (Cerebrovascular disease, Cardiac disorder, Hepatic disorders, Gastrointestinal disorder, Endocrine-related disorder, etc.) 4) Subjects who have or have a history of sleep disorders such as insomnia or sleep apnea syndrome (SAS) 5) Subjects with medication allergies, food allergies, or a serious history of such allergies 6) Subjects who have or have a history of drug addiction or alcoholism 7) Subjects who are judged by the principal investigator to have an irregular lifestyle 8) Subjects who regularly use medicines, supplements, etc. 9) Subjects who urinate more than 3 times during the night 10) Extremely heavy drinkers (more than 60g/day of alcohol) 11) Subjects who have participated in other drug or food trials within the past month, or are willing to participate during this study 12) Subjects who are judged as ineligible to participate in this study by the principal investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified